These reports are submitted through the FDA Adverse Event Reporting System (FAERS) by healthcare professionals, patients, and manufacturers to document any potential safety concerns that arise during the use of these treatments after they have been approved
Delphi Panellists Eligible panellists were actively practising healthcare professionals involved in treatment decision-making for adults with T2D and CKD in the following medical specialties: primary care, nephrology, endocrinology/diabetology, or internal medicine
Direct Meds GLP-1 Pricing: What the Company States According to pricing information published on the official Direct Meds website at the time of this report, the platform's GLP-1 medication options are structured as monthly programs
That said, newer studies are now looking more closely at whether certain GLP-1 drugs may carry a higher risk than others
Ozempic (Semaglutide) Specific Risks Ozempic, or semaglutide, is used to manage type 2 diabetes